Vaccine Ontology
810 terms(s) returned
| Term Type: Class | Record: 601 to 650 of 810 Records | Page: 13 of 17, First Previous Next Last | Show Records Per Page |
- acellular pertussis vaccine, inactivated 0.936 MG/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension
- acellular pertussis vaccine, inactivated 0.936 UNT/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension
- acellular pertussis vaccine, inactivated 160 MG/ML
- acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution
- acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution Box of 1
- acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution Box of 5
- acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution [Tussoglobin]
- acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution [Tussoglobin] Box of 1
- acellular pertussis vaccine, inactivated 160 MG/ML [Tussoglobin]
- acellular pertussis vaccine, inactivated 600 UNT/ML
- acellular pertussis vaccine, inactivated 600 UNT/ML Injectable Solution
- acellular pertussis vaccine, inactivated 8 UNT/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension
- acellular pertussis vaccine, inactivated 8 UNT/ML / diphtheria toxoid vaccine, inactivated 25 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension
- acellular pertussis vaccine, inactivated 96 UNT/ML
- acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection
- acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Pentacel]
- acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Pentacel]
- acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection
- acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Pentacel]
- acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Pentacel]
- acellular pertussis vaccine, inactivated Injectable Solution
- acellular pertussis vaccine, inactivated Injectable Solution [Acel P Lederle]
- acellular pertussis vaccine, inactivated Injectable Solution [Pac Merieux]
- acellular pertussis vaccine, inactivated Injectable Solution [Tussoglobin]
- acellular pertussis vaccine, inactivated Injectable Suspension
- acellular pertussis vaccine, inactivated Injectable Suspension [Covaxis]
- acellular pertussis vaccine, inactivated Injectable Suspension [Infanrix]
- acellular pertussis vaccine, inactivated Injectable Suspension [Pediacel]
- acellular pertussis vaccine, inactivated Injectable Suspension [Repevax]
- acellular vaccine
- actA from Listeria monocytogenes
- action specification
- active immunization
- adamantylamide dipeptide vaccine adjuvant
- adaptive immune response
- adding a material entity into a target
- adding material objective
- adenocarcinoma
- adenoviral vector Ad5 expressing SIV gag protein
- adenovirus serotype 26 vaccine vector
- adenovirus serotype 5 vaccine vector
- adenovirus vaccine
- adenovirus vaccine unspecified formulation
- adenovirus vaccine vector
- adenovirus-transfected autologous dc vaccine plus cik cells
- administering substance in vivo
- adolescence age
- adult age
- adverse event
- afluria 2015-2016 vaccine Injectable Suspension
